The most effective medicines for osteoporosis fall into two groups: drugs that slow bone breakdown, such as bisphosphonates and denosumab, and drugs that build new bone, such as teriparatide, abaloparatide, and romosozumab. Bisphosphonates are the usual first choice for most people, while bone-building drugs are reserved for those at very high fracture risk. There is no single “best” medicine; the right one depends on your fracture history, bone density, kidney function, and other health conditions.
Osteoporosis in Brief: Why Medicines Are Needed
Bone is living tissue that is constantly broken down by cells called osteoclasts and rebuilt by osteoblasts. In osteoporosis, breakdown outpaces rebuilding, so bones become thinner and more porous. The result is fragility: a fall from standing height can break a hip, wrist, or spinal bone.
Osteoporosis is often called a silent disease because it causes no symptoms until a fracture happens. Although my background is in haematology, bone health overlaps closely with blood disorders, since conditions such as myeloma and long-term steroid use damage the skeleton. Lifestyle measures help, but for people at high fracture risk, medication is what reliably reduces fractures.
Who Should Be Treated? Diagnosis and Risk Assessment
Treatment decisions start with a DEXA scan (dual-energy X-ray absorptiometry), which measures bone mineral density at the hip and spine and reports a T-score compared with a healthy young adult.
| T-score | Category |
|---|---|
| -1.0 or higher | Normal bone density |
| Between -1.0 and -2.5 | Low bone mass (osteopenia) |
| -2.5 or lower | Osteoporosis |
Density is only part of the picture. The FRAX tool combines age, sex, body weight, prior fractures, family history, smoking, alcohol, steroid use, and other factors to estimate 10-year fracture probability. Anyone who has already had a hip or spine fracture from minor trauma is generally considered to need treatment regardless of the T-score. Blood tests for calcium, vitamin D, kidney function, and sometimes thyroid and parathyroid hormones help rule out secondary causes before a drug is chosen.
Antiresorptive Medicines: Slowing Bone Loss
Bisphosphonates
Bisphosphonates bind to bone and switch off osteoclasts. Oral options include alendronate and risedronate, usually taken once weekly on an empty stomach with a full glass of water, staying upright for at least 30 minutes. Zoledronic acid is given as an intravenous infusion once a year, which suits people who cannot take tablets correctly. They reduce spine fractures and, for alendronate, risedronate, and zoledronic acid, hip fractures too.
Denosumab
Denosumab is a monoclonal antibody that blocks RANKL, a signal osteoclasts need to form. It is injected under the skin every six months and can be used when kidney function is too low for bisphosphonates. It must not be stopped abruptly: bone loss rebounds quickly after missed doses, raising the risk of multiple spine fractures, so a follow-on medicine is planned if it is discontinued.
Raloxifene and hormone therapy
Raloxifene, a selective estrogen receptor modulator (SERM), mimics estrogen in bone and reduces spine fractures, though it has not been shown to prevent hip fractures. It raises the risk of blood clots. Hormone replacement therapy protects bone and may be suitable for younger postmenopausal women who also need relief from menopausal symptoms.
Anabolic Medicines: Building New Bone
Bone-building drugs are generally used for people with severe osteoporosis, multiple fractures, or very low T-scores. Teriparatide and abaloparatide are forms of parathyroid hormone given as daily self-injections, and treatment courses are usually limited to about two years. Romosozumab blocks sclerostin, a protein that suppresses bone formation, so it both builds bone and reduces breakdown; it is given monthly for 12 months and is avoided in people who have recently had a heart attack or stroke.
Gains from anabolic drugs are lost unless they are followed by an antiresorptive, so treatment is planned as a sequence rather than a single drug.
| Medicine | How it works | How it is given | Key cautions |
|---|---|---|---|
| Alendronate, risedronate | Slow breakdown | Weekly tablet | Stomach irritation; strict dosing rules |
| Zoledronic acid | Slow breakdown | Yearly infusion | Flu-like reaction after first dose; kidney function |
| Denosumab | Slow breakdown | Injection every 6 months | Rebound bone loss if stopped; low calcium |
| Raloxifene | Estrogen-like effect on bone | Daily tablet | Blood clots; hot flashes |
| Teriparatide, abaloparatide | Build new bone | Daily injection | Limited course; follow with another drug |
| Romosozumab | Builds bone, slows breakdown | Monthly injection for 12 months | Avoid after recent heart attack or stroke |
Side Effects and Safety
Many people worry about two rare complications of long-term antiresorptive therapy: osteonecrosis of the jaw, where an area of jawbone fails to heal, and atypical femoral fractures, unusual breaks in the thigh bone. Both are rare in people treated for osteoporosis, and for most patients at high risk the fractures prevented far outnumber these events. Good dental care and telling your dentist about your medicine reduce jaw risk; new thigh or groin pain should be reported.
For people whose risk has fallen after several years of bisphosphonate treatment, a planned pause, often called a drug holiday, may be considered, because bisphosphonates remain in bone. This does not apply to denosumab.
Supplements and Lifestyle Alongside Medicine
No medicine works well if the body lacks raw materials. Most adults over 50 need around 1,000 to 1,200 mg of calcium daily, ideally mostly from food, and adequate vitamin D. Our guide to the role of supplements in osteoporosis management explains how to top up safely, and our review of the best vitamin K2 supplement for osteoporosis covers a popular add-on that should not replace proven drugs.
- Weight-bearing and muscle-strengthening exercise several times a week.
- Balance training and home safety changes to prevent falls.
- Stopping smoking and keeping alcohol within recommended limits.
Pain is a separate issue from bone density. For practical advice, see our articles on managing osteoporosis-related hip pain at night and osteoporosis pain treatment.
When to See a Doctor
Ask for a bone health assessment if you have broken a bone from a minor fall, lost noticeable height, developed a stooped posture, or take long-term steroids. Contact your doctor promptly if you are on treatment and notice new thigh or groin pain, jaw pain or exposed bone in the mouth, or severe heartburn with tablets. Never stop denosumab without a plan from your prescriber.
Frequently Asked Questions
What is the most effective medicine for osteoporosis?
For people at very high risk, bone-building drugs followed by an antiresorptive give the largest density gains. For most others, a bisphosphonate is effective, well studied, and inexpensive. The best choice depends on your individual risk profile.
How long do I need to take osteoporosis medicine?
Oral bisphosphonates are commonly reviewed after about five years and intravenous zoledronic acid after about three. Denosumab is continued long term or switched carefully. Your doctor reassesses risk with a DEXA scan and fracture history.
Can calcium and vitamin D alone treat osteoporosis?
No. They are essential foundations and help medicines work, but on their own they do not reduce fracture risk enough for someone with established osteoporosis.
Do men get osteoporosis medicines too?
Yes. Men develop osteoporosis, often later in life or due to low testosterone or steroids, and most of the same medicines are used to treat them.
